Analyst Research: Amylin Pharmaceuticals, Inc. (AMLN.O)
AMLN.O on Nasdaq
13.82USD
11:30am EST
13.82USD
11:30am EST
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$13.82
$13.82
Open
$13.90
$13.90
Day's High
$13.95
$13.95
Day's Low
$13.75
$13.75
Volume
390,156
390,156
Avg. Vol
2,015,587
2,015,587
52-wk High
$15.69
$15.69
52-wk Low
$7.89
$7.89
| Name | Age | Since | Current Position |
|---|---|---|---|
| Costa, Paulo | 2009 | Chairman of the Board | |
| Bradbury, Daniel | 48 | 2007 | President, Chief Executive Officer, Director |
| Foletta, Mark | 48 | 2006 | Chief Financial Officer, Senior Vice President - Finance |
| Lloyd, Marcea | 60 | 2007 | Senior Vice President - Government and Corporate Affairs, General Counsel |
| Mihalik, Vincent | 58 | 2009 | Senior Vice President - Sales and Marketing, Chief Commercial Officer |
© Copyright 2009 Thomson Reuters
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
